Scarica l'app Stockscreener
7.58
1.04%
-0.08
Dopo l'orario di chiusura:
7.50
-0.08
-1.06%
Precedente Chiudi:
$7.66
Aprire:
$7.5
Volume 24 ore:
30,544
Relative Volume:
0.37
Capitalizzazione di mercato:
$19.21M
Reddito:
-
Utile/perdita netta:
$-11.74M
Rapporto P/E:
-0.7171
EPS:
-10.5698
Flusso di cassa netto:
$-9.50M
1 W Prestazione:
+29.79%
1M Prestazione:
-17.32%
6M Prestazione:
+10.25%
1 anno Prestazione:
-87.04%
Intervallo 1D:
$7.50
$7.70
Intervallo di 1 settimana:
$5.76
$8.055
Portata 52W:
$4.6325
$62.49
Intensity Therapeutics Inc Stock (INTS) Company Profile
Nome
Intensity Therapeutics Inc
Settore
Industria
Telefono
203-221-7381
Indirizzo
1 ENTERPRISE DRIVE, SUITE 430, SHELTON
Compare INTS vs VRTX, REGN, ARGX, ALNY, ONC
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
INTS
Intensity Therapeutics Inc
|
7.58 | 19.41M | 0 | -11.74M | -9.50M | -10.57 |
|
VRTX
Vertex Pharmaceuticals Inc
|
486.03 | 126.21B | 12.07B | 3.95B | 3.19B | 15.33 |
|
REGN
Regeneron Pharmaceuticals Inc
|
790.81 | 82.64B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
756.76 | 47.46B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
325.07 | 44.15B | 3.71B | 313.75M | 465.38M | 2.2571 |
|
ONC
Beone Medicines Ltd Adr
|
314.36 | 35.08B | 4.98B | 69.60M | 525.67M | 0.5198 |
Intensity Therapeutics Inc Borsa (INTS) Ultime notizie
Surprises Report: Whats next for Intensity Therapeutics Inc stock2025 Retail Activity & Free Community Consensus Stock Picks - baoquankhu1.vn
Buy Signal: Should I set a stop loss on Intensity Therapeutics IncJuly 2025 Earnings & Accurate Buy Signal Alerts - baoquankhu1.vn
Sentiment Watch: Can MAAS deliver alphaWeekly Risk Summary & Weekly High Potential Alerts - baoquankhu1.vn
Can Intensity Therapeutics Inc. stock beat market expectations this quarterWeekly Trade Analysis & Low Risk Investment Opportunities - mfd.ru
Is Intensity Therapeutics Inc.’s growth already priced inQuarterly Market Review & AI Enhanced Trading Signals - mfd.ru
Why did INTS stock plummet 25% today? - MSN
Why did INTS stock plummet 30% pre-market today? - MSN
CT biotech firm plans reverse stock split to regain Nasdaq compliance - Hartford Business Journal
What's going on with Intensity Therapeutics stock Friday? - MSN
Can Intensity Therapeutics Inc. disrupt its industryPortfolio Risk Report & Free Community Consensus Stock Picks - mfd.ru
Why Did INTS Stock Plummet 25% Today? - Stocktwits
Growth Review: Can Intensity Therapeutics Inc benefit from deglobalizationQuarterly Profit Review & Free Reliable Trade Execution Plans - baoquankhu1.vn
Intensity Therapeutics announces 1-for-25 reverse stock split By Investing.com - Investing.com Australia
Intensity Therapeutics Announces 1-for-25 Reverse Stock Split - TipRanks
Intensity Therapeutics (Nasdaq: INTS) Stock: Announces 1-for-25 Reverse Split to Meet Nasdaq Rule - CoinCentral
What's Going On With Intensity Therapeutics Stock Friday? - Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session - Benzinga
Intensity Therapeutics announces 1-for-25 reverse stock split - Investing.com
Intensity Therapeutics announces reverse stock split - marketscreener.com
Why Did INTS Stock Plummet 30% Pre-Market Today? - Menafn.com
Intensity Therapeutics Announces Reverse Stock Split - TradingView
Will Intensity Therapeutics Inc. stock gain from government policiesJuly 2025 Patterns & Low Risk High Win Rate Stock Picks - mfd.ru
All you need to know about Intensity Therapeutics Inc. (INTS) rating upgrade to buy - MSN
Weekly Earnings: Is SVRA a cyclical or defensive stockQuarterly Performance Summary & Technical Confirmation Alerts - baoquankhu1.vn
Intensity Therapeutics Gains AttentionStock Up 8% - Nasdaq
Risk Report: Is BRLSW affected by consumer sentimentWeekly Gains Summary & Verified Entry Point Detection - baoquankhu1.vn
Recap Report: Is Smithfield Foods Inc showing insider buyingGap Up & Reliable Volume Spike Alerts - baoquankhu1.vn
Why Is Retail Going Gaga Over INTS Stocks Today? - MSN
Volume Summary: Is Faraday Future Intelligent Electric Inc being accumulated by smart moneyLayoff News & Technical Buy Zone Confirmations - baoquankhu1.vn
Chart Watch: Is Intensity Therapeutics Inc stock a top performer YTD2025 Geopolitical Influence & Weekly High Return Stock Opportunities - baoquankhu1.vn
Stop Loss: Can Intensity Therapeutics Inc. ride the EV waveAnalyst Downgrade & Low Risk Investment Opportunities - baoquankhu1.vn
Should I hold or sell Intensity Therapeutics Inc. stock in 20252025 Short Interest & Stepwise Entry and Exit Trade Signals - bollywoodhelpline.com
Aug Mood: How do insiders feel about OptiNose Inc2025 Performance Recap & Low Drawdown Momentum Ideas - baoquankhu1.vn
Intensity therapeutics outlines 2026 priorities after clinical validation By Investing.com - Investing.com India
Layoff Watch: Is Intensity Therapeutics Inc stock a top pick in earnings season2025 Geopolitical Influence & High Conviction Trade Alerts - Bộ Nội Vụ
Intensity therapeutics outlines 2026 priorities after clinical validation - Investing.com
Intensity Therapeutics highlights 2025 milestones and outlines 2026 strategic priorities - marketscreener.com
Intensity Therapeutics Highlights 2025 Milestones and Outlines 2026 Strategic Priorities - PR Newswire
Is Intensity Therapeutics Inc stock influenced by commodity pricesJuly 2025 Recap & Real-Time Volume Spike Alerts - baoquankhu1.vn
What insider trading reveals about Intensity Therapeutics Inc. stockEntry Point & Growth Oriented Trade Recommendations - Улправда
Why Intensity Therapeutics Inc. stock is rated strong buyLightweight Speed Options & trail grip notes for mixed terrain - Улправда
Can Intensity Therapeutics Inc. stock rebound after recent weaknessJuly 2025 Analyst Calls & Precise Entry and Exit Recommendations - Улправда
Can Intensity Therapeutics Inc. stock attract ESG capital inflowsShort Setup & Technical Pattern Alert System - Улправда
Why Intensity Therapeutics Inc. stock appeals to analysts2026 world cup usa national team group stage playmakers set piece tactics expert forecast analysis - Улправда
Intratumoral Cancer Therapies Market Expected to Gain Momentum Through 2034, According to DelveInsight - openPR.com
Intensity Therapeutics Inc Azioni (INTS) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
2.90%
2.73%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):